HIV starts when the virus enters your body through specific routes, most commonly sexual contact or shared needles, and targets a particular type of immune cell. From there, the infection unfolds in a predictable pattern: a hidden phase where the virus multiplies silently, a burst of flu-like symptoms in most people, and then a long quiet period where damage accumulates without obvious signs. Understanding each phase helps you recognize what’s happening and act quickly if you’ve been exposed.
How HIV Gets Into Your Cells
HIV is extremely specific about which cells it attacks. The virus targets CD4 T-cells, white blood cells that coordinate your immune response. To get inside, HIV’s outer protein latches onto two receptors on the surface of these cells: first the CD4 receptor, then a second receptor called a coreceptor. Think of it like a two-key lock. The virus can’t get in without engaging both.
Once attached, the virus triggers the cell to rearrange its internal scaffolding, essentially tricking the cell into pulling the virus inside. From there, HIV inserts its own genetic code into the cell’s DNA, turning the cell into a factory for producing more virus. Those new copies spill out and infect other CD4 cells, and the cycle accelerates rapidly.
The Eclipse Period: Silent Replication
For roughly the first 11 to 12 days after exposure (though it can range from 5 to 33 days), the virus replicates near the site of infection in cells just below the mucosal surface. During this time, called the eclipse period, HIV isn’t detectable in the bloodstream by any test, not even the most sensitive lab assays. You feel completely normal, and no blood draw would reveal anything.
This is the critical window for post-exposure prophylaxis, or PEP. If you believe you’ve been exposed, starting PEP within 72 hours can reduce the risk of infection by about 81%. The sooner you start, the better it works. After 72 hours, it’s unlikely to help. PEP involves taking antiretroviral medication daily for 28 days.
Transmission Risk by Activity
Not every exposure carries the same risk. CDC data based on systematic reviews of transmission studies shows the estimated per-act probability of getting HIV when no protection is used:
- Receptive anal sex: about 1 in 72
- Insertive anal sex: about 1 in 909
- Receptive vaginal sex: about 1 in 1,250
- Insertive vaginal sex: about 1 in 2,500
These are averages. The actual risk in any single encounter depends on factors like viral load, the presence of other sexually transmitted infections, and whether there are breaks in the skin or mucous membranes. Sharing needles carries a higher risk than most sexual exposures because blood-to-blood contact is extremely efficient at transmitting the virus.
The Viral Explosion
Once HIV reaches the bloodstream, it replicates at a staggering pace. During the peak of acute infection, viral load typically climbs to around 1 million copies per milliliter of blood. This is the point at which the virus is most concentrated in your body and you are most infectious to others, often before you even know you’re infected.
At the same time, your CD4 count drops sharply. These are the very immune cells your body needs to fight infections, and HIV is destroying them faster than your body can replace them. After several weeks, your immune system mounts a partial counterattack. Specialized killer cells beat back the virus, viral load drops to a lower “set point,” and CD4 counts partially rebound. But the virus is never fully cleared. It hides in long-lived cells where the immune system can’t reach it.
What Acute Infection Feels Like
About 2 to 4 weeks after exposure, most people experience symptoms. In one community-based screening study, 78% of people with newly confirmed acute HIV infection had symptoms consistent with the illness. Only about 7% were completely asymptomatic.
The symptoms resemble a bad flu or mono: fever, headache, rash, sore throat, swollen lymph nodes, muscle aches, and fatigue. They typically appear suddenly and can be intense enough to send people to urgent care. The trouble is that these symptoms overlap with dozens of common illnesses, so they’re easy to dismiss. About half of the people in the screening study still had symptoms at the time of their diagnosis, while another 28% recalled symptoms in the two weeks before testing.
These symptoms generally last one to two weeks and then fade on their own, regardless of whether you seek care. The disappearance of symptoms does not mean the infection is gone. It means the virus has settled into a chronic phase.
When Tests Can Detect It
Different HIV tests become reliable at different points after exposure. Knowing which test you’re getting matters, because testing too early with the wrong type can give a false negative.
- Nucleic acid tests (NAT): detect the virus’s genetic material directly. Reliable 10 to 33 days after exposure.
- Lab-based antigen/antibody tests (blood draw from a vein): detect both viral proteins and your body’s antibodies. Reliable 18 to 45 days after exposure.
- Rapid antigen/antibody tests (finger stick): same principle but less sensitive. Reliable 18 to 90 days after exposure.
- Antibody-only tests: detect only your immune response, not the virus itself. Reliable 23 to 90 days after exposure.
If you test negative but the exposure was recent, you may need to retest after the window period has passed. A negative result within the first few weeks doesn’t necessarily mean you’re in the clear.
What Happens After the Acute Phase
Once acute symptoms resolve, HIV enters what’s called clinical latency, sometimes called the chronic stage. The virus continues replicating at lower levels, and CD4 counts gradually decline over years. Without treatment, this stage typically lasts a decade or so before the immune system weakens enough for serious infections to take hold, the point at which HIV has progressed to AIDS.
With modern antiretroviral treatment, this progression can be halted almost entirely. Treatment drives viral load down to undetectable levels, preserves CD4 counts, and prevents transmission to others. The earlier treatment begins, the better the long-term outcome. People who start treatment during the acute phase tend to have smaller viral reservoirs and stronger immune recovery than those who begin years later.